These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 18805838

  • 1. An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
    Koutsis G, Panas M, Giogkaraki E, Karadima G, Sfagos C, Vassilopoulos D.
    Mult Scler; 2009 Feb; 15(2):174-9. PubMed ID: 18805838
    [Abstract] [Full Text] [Related]

  • 2. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
    Koutsis G, Panas M, Giogkaraki E, Potagas C, Karadima G, Sfagos C, Vassilopoulos D.
    Neurology; 2007 Feb 20; 68(8):546-9. PubMed ID: 17310023
    [Abstract] [Full Text] [Related]

  • 3. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J, Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM.
    Neurology; 2008 Jan 15; 70(3):185-90. PubMed ID: 17460153
    [Abstract] [Full Text] [Related]

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G, COGIMUS Study Group.
    Mult Scler; 2009 Jul 15; 15(7):779-88. PubMed ID: 19542262
    [Abstract] [Full Text] [Related]

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.
    Encephale; 2008 Dec 15; 34(6):557-62. PubMed ID: 19081451
    [Abstract] [Full Text] [Related]

  • 6. Cognitive impairment in different MS subtypes and clinically isolated syndromes.
    Potagas C, Giogkaraki E, Koutsis G, Mandellos D, Tsirempolou E, Sfagos C, Vassilopoulos D.
    J Neurol Sci; 2008 Apr 15; 267(1-2):100-6. PubMed ID: 17997417
    [Abstract] [Full Text] [Related]

  • 7. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
    Portaccio E, Amato MP, Bartolozzi ML, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N.
    J Neurol Sci; 2006 Jun 15; 245(1-2):195-9. PubMed ID: 16631794
    [Abstract] [Full Text] [Related]

  • 8. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
    Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, De Stefano N.
    Neurology; 2008 Aug 26; 71(9):632-8. PubMed ID: 18725589
    [Abstract] [Full Text] [Related]

  • 9. Association of the STin2 polymorphism of the serotonin transporter gene with a neurocognitive endophenotype in major depressive disorder.
    Sarosi A, Gonda X, Balogh G, Domotor E, Szekely A, Hejjas K, Sasvari-Szekely M, Faludi G.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct 01; 32(7):1667-72. PubMed ID: 18647635
    [Abstract] [Full Text] [Related]

  • 10. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of the cannabinoid 1 receptor gene and cognitive impairment in multiple sclerosis.
    Woolmore J, Stone M, Holley S, Jenkinson P, Ike A, Jones P, Fryer A, Strange R, Stephens R, Langdon D, Hawkins C.
    Mult Scler; 2008 Mar 18; 14(2):177-82. PubMed ID: 17942526
    [Abstract] [Full Text] [Related]

  • 12. Cognitive performance in elderly women: significance of the 19bp insertion/deletion polymorphism in the 5' flank of the dopamine beta-hydroxylase gene, educational level, body fat measures, serum triglyceride, alcohol consumption and age.
    Togsverd M, Werge TM, Tankó LB, Bagger YZ, Qin GG, Hansen T, Christiansen C, Rasmussen HB.
    Int J Geriatr Psychiatry; 2007 Sep 18; 22(9):883-9. PubMed ID: 17200925
    [Abstract] [Full Text] [Related]

  • 13. T-1237C polymorphism of TLR9 gene is not associated with multiple sclerosis in the Portuguese population.
    Carvalho A, Santos M, Maciel P, Rodrigues F.
    Mult Scler; 2008 May 18; 14(4):550-2. PubMed ID: 18208876
    [Abstract] [Full Text] [Related]

  • 14. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E, Goretti B, Zipoli V, Siracusa G, Sorbi S, Amato MP.
    Clin Neuropsychol; 2009 Feb 18; 23(2):268-75. PubMed ID: 18609336
    [Abstract] [Full Text] [Related]

  • 15. Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery.
    Portaccio E, Goretti B, Zipoli V, Iudice A, Pina DD, Malentacchi GM, Sabatini S, Annunziata P, Falcini M, Mazzoni M, Pia Amato M, TuSCIMS Study Group.
    Mult Scler; 2010 May 18; 16(5):611-7. PubMed ID: 20207783
    [Abstract] [Full Text] [Related]

  • 16. Cognitive functioning in children with multiple sclerosis.
    Montiel-Nava C, Peña JA, González-Pernía S, Mora-La Cruz E.
    Mult Scler; 2009 Feb 18; 15(2):266-8. PubMed ID: 18922833
    [Abstract] [Full Text] [Related]

  • 17. The SH2D2A gene and susceptibility to multiple sclerosis.
    Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF.
    J Neuroimmunol; 2008 Jul 15; 197(2):152-8. PubMed ID: 18554728
    [Abstract] [Full Text] [Related]

  • 18. ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.
    Albahrani AI, Usher JJ, Alkindi M, Marks E, Ranganath L, Al-yahyaee S.
    Lipids Health Dis; 2007 Aug 06; 6():19. PubMed ID: 17683612
    [Abstract] [Full Text] [Related]

  • 19. Cognitive dysfunction in multiple sclerosis: methods and prevalence from the GEDMA Study.
    Olazarán J, Cruz I, Benito-León J, Morales JM, Duque P, Rivera-Navarro J.
    Eur Neurol; 2009 Aug 06; 61(2):87-93. PubMed ID: 19039226
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L, Englert J, Munschauer F, Weinstock-Guttman B, Rao S, Benedict RH.
    Mult Scler; 2009 Sep 06; 15(9):1077-84. PubMed ID: 19556311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.